Skip to content

Clinical trials

Observational Heart Failure trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Observational Country / region: Japan Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20102
20111
20122
20131
20143
20151
20161
20173
20182
20211
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Recruiting2
Terminated2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene4
Abbott Medical Devices3
Biotronik SE & Co. KG2
Boston Scientific Corporation2
AstraZeneca1
Boehringer Ingelheim1
Carolyn Lam1
Hiroaki Shimokawa, MD, PhD1
Kyoto University, Graduate School of Medicine1
Medtronic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure23
Arrhythmias, Cardiac7
Hypersensitivity4
Infections4
Lung Diseases, Interstitial4
Peripheral Nervous System Diseases4
Teratogenesis4
Tumor Lysis Syndrome4
Cardiovascular Diseases3
Hemorrhage3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.